Clinical Trial Update: Gene Therapy Trial for Platelet Derived Factor VIII Production in Hemophilia A [Phase 1]

View source ↗

Summary

A Phase 1 gene therapy trial aims to produce Factor VIII in platelets to treat Hemophilia A; the study status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Platelet-derived Factor VIII gene therapy

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Hemophilia A | Phase 1 | Status: ACTIVE_NOT_RECRUITING